General MedicationsORALGeneric
CHILDREN'S ALLEGRA HIVES
FEXOFENADINE HYDROCHLORIDE
Standard Dose
30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Discontinued
Key Takeaways
- Primary indication: Review priority: N/A Marketing status: Discontinued
- Approval overview CHILDREN'S ALLEGRA HIVES is listed in Drugs@FDA under application 201373 (NDA).
- Review priority: N/A Marketing status: Discontinued Active ingredient FEXOFENADINE HYDROCHLORIDE Form and strength SUSPENSION;ORAL - 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor CHATTEM SANOFI Submission history Latest submission status date: 2022-12-27 00:00:00.
Structured Monograph
Clinical summary
Approval overview CHILDREN'S ALLEGRA HIVES is listed in Drugs@FDA under application 201373 (NDA). Review priority: N/A Marketing status: Discontinued Active ingredient FEXOFENADINE HYDROCHLORIDE Form and strength SUSPENSION;ORAL - 30MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor CHATTEM SANOFI Submission history Latest submission status date: 2022-12-27 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: N/A
Interaction Notes
- No interaction notes stored yet.